Verilumia 
Novo Nordisk Rebrands as Novo to Regain Obesity Drug Market Lead
Novo Nordisk, the Danish pharmaceutical company behind the weight-loss drugs Ozempic and Wegovy, announced a rebrand on Monday, shortening its day-to-day name to simply "Novo" in an effort to become more recognizable...
